BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tatsumi K, Mitani Y, Watanabe J, Takakura H, Hoshi K, Kawai Y, Kikuchi T, Kogo Y, Oguchi-Katayama A, Tomaru Y. Rapid screening assay for KRAS mutations by the modified smart amplification process. J Mol Diagn. 2008;10:520-526. [PMID: 18832461 DOI: 10.2353/jmoldx.2008.080024] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Guo GF, Jiang WQ, Zhang B, Cai YC, Xu RH, Chen XX, Wang F, Xia LP. Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer. World J Gastroenterol 2011; 17(43): 4779-4786 [PMID: 22147978 DOI: 10.3748/wjg.v17.i43.4779] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
2 Araki T, Shimizu K, Nakamura K, Nakamura T, Mitani Y, Obayashi K, Fujita Y, Kakegawa S, Miyamae Y, Kaira K, Ishidao T, Lezhava A, Hayashizaki Y, Takeyoshi I, Yamamoto K. Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods. J Mol Diagn 2010;12:118-24. [PMID: 20007840 DOI: 10.2353/jmoldx.2010.090081] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
3 Duan Q, Li X, He X, Shen X, Cao Y, Zhang R, Bai X, Zhang J, Ma X. A duplex probe-directed recombinase amplification assay for detection of single nucleotide polymorphisms on 8q24 associated with prostate cancer. Braz J Med Biol Res 2020;54:e9549. [PMID: 33263645 DOI: 10.1590/1414-431X20209549] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Jancík S, Drábek J, Radzioch D, Hajdúch M. Clinical relevance of KRAS in human cancers. J Biomed Biotechnol. 2010;2010:150960. [PMID: 20617134 DOI: 10.1155/2010/150960] [Cited by in Crossref: 114] [Cited by in F6Publishing: 123] [Article Influence: 9.5] [Reference Citation Analysis]
5 Oliveira BB, Veigas B, Baptista PV. Isothermal Amplification of Nucleic Acids: The Race for the Next “Gold Standard”. Front Sens 2021;2:752600. [DOI: 10.3389/fsens.2021.752600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kitano S, Nakayama M, Yamane A, Tsukahara Y, Amano M. Detection of DNA mutations by fluorescence resonance energy transfer-based preferential homoduplex formation assay. Analytical Biochemistry 2011;408:197-205. [DOI: 10.1016/j.ab.2010.09.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
7 Kondratova VN, Botezatu IV, Shelepov VP, Lichtenstein AV. SLAM-MS: Mutation scanning of stem-loop amplicons with TaqMan probes by quantitative DNA melting analysis. Sci Rep 2020;10:5476. [PMID: 32214156 DOI: 10.1038/s41598-020-62173-x] [Reference Citation Analysis]
8 Plesec TP, Hunt JL. KRAS mutation testing in colorectal cancer. Adv Anat Pathol 2009;16:196-203. [PMID: 19546608 DOI: 10.1097/PAP.0b013e3181a9d4ed] [Cited by in Crossref: 85] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
9 Kakegawa S, Shimizu K, Sugano M, Miyamae Y, Kaira K, Araki T, Nakano T, Kamiyoshihara M, Kawashima O, Takeyoshi I. Clinicopathological features of lung adenocarcinoma with KRAS mutations. Cancer 2011;117:4257-66. [PMID: 21387273 DOI: 10.1002/cncr.26010] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
10 Song J, Hegge JW, Mauk MG, Chen J, Till JE, Bhagwat N, Azink LT, Peng J, Sen M, Mays J, Carpenter EL, van der Oost J, Bau HH. Highly specific enrichment of rare nucleic acid fractions using Thermus thermophilus argonaute with applications in cancer diagnostics. Nucleic Acids Res 2020;48:e19. [PMID: 31828328 DOI: 10.1093/nar/gkz1165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
11 Kalendar R, Khassenov B, Ramankulov Y, Samuilova O, Ivanov KI. FastPCR: An in silico tool for fast primer and probe design and advanced sequence analysis. Genomics 2017;109:312-9. [PMID: 28502701 DOI: 10.1016/j.ygeno.2017.05.005] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 12.0] [Reference Citation Analysis]
12 [DOI: 10.1101/491738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Craw P, Balachandran W. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab Chip. 2012;12:2469-2486. [PMID: 22592150 DOI: 10.1039/c2lc40100b] [Cited by in Crossref: 447] [Cited by in F6Publishing: 363] [Article Influence: 44.7] [Reference Citation Analysis]
14 Atsumi J, Hanami T, Enokida Y, Ogawa H, Delobel D, Mitani Y, Kimura Y, Soma T, Tagami M, Takase Y, Ichihara T, Takeyoshi I, Usui K, Hayashizaki Y, Shimizu K. Eprobe-mediated screening system for somatic mutations in the KRAS locus. Oncol Rep 2015;33:2719-27. [PMID: 25823645 DOI: 10.3892/or.2015.3883] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ishikawa T, Sakurai A, Hirano H, Lezhava A, Sakurai M, Hayashizaki Y. Emerging New Technologies in Pharamcogenomics: Rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1). Pharmacology & Therapeutics 2010;126:69-81. [DOI: 10.1016/j.pharmthera.2010.01.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
16 Miyamae Y, Shimizu K, Mitani Y, Araki T, Kawai Y, Baba M, Kakegawa S, Sugano M, Kaira K, Lezhava A, Hayashizaki Y, Yamamoto K, Takeyoshi I. Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue. J Mol Diagn 2010;12:257-64. [PMID: 20093389 DOI: 10.2353/jmoldx.2010.090105] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
17 Kalendar R, Muterko A, Shamekova M, Zhambakin K. In Silico PCR Tools for a Fast Primer, Probe, and Advanced Searching. Methods Mol Biol 2017;1620:1-31. [PMID: 28540697 DOI: 10.1007/978-1-4939-7060-5_1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
18 Vestheim H, Deagle BE, Jarman SN. Application of blocking oligonucleotides to improve signal-to-noise ratio in a PCR. Methods Mol Biol 2011;687:265-74. [PMID: 20967615 DOI: 10.1007/978-1-60761-944-4_19] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
19 Shagin DA, Turchaninova MA, Shagina IA, Shugay M, Zaretsky AR, Zueva OI, Bolotin DA, Lukyanov S, Chudakov DM. Application of nonsense-mediated primer exclusion (NOPE) for preparation of unique molecular barcoded libraries. BMC Genomics 2017;18:440. [PMID: 28583065 DOI: 10.1186/s12864-017-3815-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Kitano S, Myers J, Nakamura J, Yamane A, Yamashita M, Nakayama M, Tsukahara Y, Ushida H, Liu W, Ratain MJ. A novel fully automated molecular diagnostic system (AMDS) for colorectal cancer mutation detection. PLoS One. 2013;8:e62989. [PMID: 23671647 DOI: 10.1371/journal.pone.0062989] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
21 Myers MB, Wang Y, McKim KL, Parsons BL. Hotspot oncomutations: implications for personalized cancer treatment. Expert Rev Mol Diagn 2012;12:603-20. [PMID: 22845481 DOI: 10.1586/erm.12.51] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
22 Botezatu IV, Kondratova VN, Shelepov VP, Mazurenko NN, Tsyganova IV, Susova OY, Lichtenstein AV. Asymmetric mutant-enriched polymerase chain reaction and quantitative DNA melting analysis of KRAS mutation in colorectal cancer. Anal Biochem 2020;590:113517. [PMID: 31782995 DOI: 10.1016/j.ab.2019.113517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Kaneko Y, Kuramochi H, Nakajima G, Inoue Y, Yamamoto M. Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases. Int J Clin Oncol 2014;19:113-20. [PMID: 23299277 DOI: 10.1007/s10147-012-0507-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
24 Botezatu IV, Nechaeva IO, Stroganova АМ, Senderovich AI, Kondratova VN, Shelepov VP, Lichtenstein AV. Optimization of melting analysis with TaqMan probes for detection of KRAS, NRAS, and BRAF mutations. Analytical Biochemistry 2015;491:75-83. [DOI: 10.1016/j.ab.2015.09.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
25 Mitani Y, Lezhava A, Sakurai A, Horikawa A, Nagakura M, Hayashizaki Y, Ishikawa T. Rapid and cost-effective SNP detection method: application of SmartAmp2 to pharmacogenomics research. Pharmacogenomics 2009;10:1187-97. [PMID: 19604094 DOI: 10.2217/pgs.09.39] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
26 Morlighem JÉ, Harbers M, Traeger-Synodinos J, Lezhava A. DNA amplification techniques in pharmacogenomics. Pharmacogenomics 2011;12:845-60. [PMID: 21692615 DOI: 10.2217/pgs.11.10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Sharafdarkolaee SH, Gill P, Motovali-Bashi M, Sharafdarkolaee FH. Isothermal Amplification Methods for the SNP Genotyping. Curr Mol Med 2019;19:461-72. [PMID: 31131752 DOI: 10.2174/1566524019666190527083947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Liu Y, Lei T, Liu Z, Kuang Y, Lyu J, Wang Q. A Novel Technique to Detect EGFR Mutations in Lung Cancer. Int J Mol Sci 2016;17:E792. [PMID: 27223277 DOI: 10.3390/ijms17050792] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
29 Riely GJ, Ladanyi M. KRAS mutations: an old oncogene becomes a new predictive biomarker. J Mol Diagn. 2008;10:493-495. [PMID: 18832458 DOI: 10.2353/jmoldx.2008.080105] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
30 Song J, Liu C, Mauk MG, Peng J, Schoenfeld T, Bau HH. A Multifunctional Reactor with Dry-Stored Reagents for Enzymatic Amplification of Nucleic Acids. Anal Chem 2018;90:1209-16. [PMID: 29226671 DOI: 10.1021/acs.analchem.7b03834] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
31 Enokida Y, Shimizu K, Atsumi J, Lezhava A, Tanaka Y, Kimura Y, Soma T, Hanami T, Kawai Y, Usui K, Okano Y, Kakegawa S, Ogawa H, Miyamae Y, Miyagi Y, Nakayama H, Ishikawa T, Hayashizaki Y, Takeyoshi I. Rapid detection of SNP (c.309T>G) in the MDM2 gene by the Duplex SmartAmp method. PLoS One 2013;8:e60151. [PMID: 23565197 DOI: 10.1371/journal.pone.0060151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]